Management of Treatment-Resistant Depression: Challenges and Strategies

Cited by (448)

Items 301–400 of 448

1. Opyt primeneniya Stenfordskoj nejromoduliruyushchej terapii u pacientov s terapevticheski rezistentnoj depressiej
   А. Г. Пойдашева, И. С. Бакулин, Dmitry O. Sinitsyn, Alfiia Kh. Zabirova, Н. А. Супонева, Nikita Maslenikov, Цукарзи Эдуард Эдуардович, С.Н. Мосолов, М. А. Пирадов · 2022 · Вестник Российского государственного медицинского университета
2. On stimulus persistence and human behavior: the stimulus persistence unification theory
   Tobore Onojighofia Tobore · 2022 · Communicative & Integrative Biology
3. Effect of ketamine infusion in treatment resistant depression and in depressive patients with active suicidal ideations: a study from North India
   Ubaid Rasool, Neelofer Jan, Marya Zahoor, Fazle Roub, Yasir Hassan Rather, Arshad Hussain, Rukhsana Najeeb · 2023 · International Journal of Research in Medical Sciences
4. Comparison of the Effectiveness of Transcranial Magnetic Stimulation Protocols as an Adjunct to the Pharmacotherapy of Refractory Depression with Comorbid Chronic Pain
   D. S. Petelin, V. E. Bezrukov, R. M. Shishorin, Beatrice A. Volel · 2023 · Neuroscience and Behavioral Physiology
5. Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index
   Benjamin Wade, Ryan Pindale, Joan Albert Camprodon, James Luccarelli, Shuang Li, Robert C. Meisner, Stephen J. Seiner, Michael Henry · 2023 · Research Square
6. The Polypharmacology of Cariprazine and its Implications to Clinical Indications
   Attila Egyed, Dóra Judit Kiss, György Miklós Keserű · 2024
7. Excitation-Inhibition Balance and Fronto-Limbic Connectivity Drive TMS Treatment Outcomes in Refractory Depression
   Davide Momi, Zheng Wang, Mohammad P. Oveisi, Kevin Kadak, Sorenza P Bastiaens, Jennifer I. Lissemore, Yoshihiro Noda, Jonathan H. Downar, Fidel Vila‐Rodriguez, Rebecca Strafella et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
8. Real-world evidence from a European cohort study of patients with treatment resistant depression: Country-specific data for Portugal
   João Miguel Bessa, Gonçalo Cotovio, Orlando von Doellinger, Juliana Pierami de Freitas, Elvira Lara, Ana Matos-Pires, Madalena Serra, Gonçalo Amorim, A. Filipa Pereira, Albino Jorge Oliveira-Maia · 2024 · Journal of Affective Disorders Reports
9. Ketamine Usage Effectivity on Treatment-Resistant Depression Diagnosed Patients: a Scoping Review
   Satrio Wahyu Nugroho, Agustina Konginan, Gadis Meinar Sari, Erikavitri Yulianti · 2024 · Jurnal Psikiatri Surabaya
10. Peer-led intervention for individuals with major depression: study protocol for a randomized controlled trial (SUPEERMood)
    Xandra Gonzalez-Garcia, M. Lucia Moreno-Sancho, Patricia Roa-Díez, Yolanda Caceres-Tejeiro, Sarah-Louise d’Auvergne Flowers, Concha Gómez de Montes, Miquel Bennasar‐Veny, Mauro Garcı́a-Toro, Aina M. Yáñez · 2024 · BMC Psychiatry
11. Comparative Side‐Effects of Neurosurgical Treatment of Treatment‐Resistant Depression
    Alexandre Lim Eng Keat, Keith Tan Jian Li, Chuin Hau Teo, Tomoko Soga · 2024 · CNS Neuroscience & Therapeutics
12. Molecular signature underlying (R)-ketamine rapid antidepressant response on anhedonic-like behavior induced by sustained exposure to stress
    Ellen Scotton, Paola Rampelotto Ziani, Renata Luiza Boff Wilges, Pedro Henrique da Rosa Correa, Lucas Azambuja Giordano, Jéferson Ferraz Goularte, Tainá Schons, Felipe Borges Almeida, Dirson João Stein, Josimar Macedo de Castro et al. · 2024 · Pharmacology Biochemistry and Behavior
13. Feasibility and clinical effects of accelerated sequential bilateral theta burst stimulation in late-life depression (ACCELDER Trial)
    Jeanette Hui, Alisson Paulino Trevizol, Caroline Wanderley Espinola, Radhika Suneel Kelkar, Hyewon Helen Lee, Benoit H. Mulsant, Jake Prillo, Reza Zomorrodi, Christoph Zrenner, Daniel M. Blumberger · 2025 · Transcranial magnetic stimulation .
14. Pregabalin Use in Treatment-Resistant Depression: A Case Report
    Devon A McCoy, Sadie R Walter, Matthew Bogoyas · 2025 · Cureus
15. Antidepressant-like activities of Entada africana Guill. & Perr. (Fabaceae) leaf extract and its chloroform and n-butanol fractions in mice: exploring mechanistic pathways
    Mukhtar Yahya Bebeji, Abdullahi Hamza Yaro, Abdullahi Rabiu Abubakar · 2025 · Bulletin of the National Research Centre/Bulletin of the National Research Center
16. Managing the risk of suicide in people with treatment-resistant depression
    Peter J. Franz, Jonathan E. Alpert · 2022 · Elsevier eBooks
17. Development of Drug Delivery Systems Based on New Concepts
    Chikamasa Yamashita · 2025 · YAKUGAKU ZASSHI
18. Korean Medication Algorithm Project for Depressive Disorder 2025 (I): Treatment Strategies for Major Depressive Episode
    Won-Seok Choi, Young Sup Woo, Won‐Myong Bahk, Nak-Young Kim, Sung‐Yong Park, Won Kim, Jung Goo Lee, Chan-Mo Yang, Hyung Mo Sung, Sheng‐Min Wang et al. · 2025 · 신경정신의학
19. Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression
    Kristin Clemens, Benoît Rive, Kruti Joshi, Pushpike J. Thilakarathne, Noam Y. Kirson, Urvi S. Desai, Jason Doran, Diab Eid, Alice Qu, Yordan Godinov · 2025 · Current Medical Research and Opinion
20. Navigating Therapies, Challenges, and Recommendations for Treatment-Resistant Peripartum Depression: A Comprehensive Review
    Afshan Zeeshan Wasti, Sarah Almutairi, Mohsina Huq, Amal Hussain, Amal Mohamad Husein Mackawy, Farah Jabeen, Basmah F. Alharbi, Anjuman Gul Memon, M. Ahmed · 2025 · Healthcare
21. Hemp Proteins Conjugated with Green Tea Polyphenol Extract Form De Novo Plant‐Sourced Emulsifiers Suitable for Nanodelivery Systems Bearing Lipophilic Psychopharmaceuticals
    William Charles Hosie, Abhinandan Banerjee, Mary Augustina Egbuta, Kasra Razmkhah, Behzad Bolandi, Khalilalrahman Dehvari, Anton A. Homon, Aleena Kappadakunnel, Jonathan J. Simone, John Frederick Trant · 2025 · Advanced Therapeutics
22. Applications of machine learning in deep brain stimulation for major depressive disorder: a systematic review and meta-analysis
    Marios G. Lampros, Solonas Symeou, Γεώργιος Αλεξίου, Spyridon Voulgaris, Antonios Mammis · 2025 · Neurosurgical Review
23. Exploring the applications of molecularly imprinted polymers in drug delivery to the nervous system
    Hooman Pourbala, Fateme Peyvand, Sepehr Izadi, Shahin Jafari Ashtiani, Dorsan Rabbanian, Niki Pouyanfar, Kamran Banan, Mohammad‐Ali Shahbazi, Mehrdad Faizi, Fatemeh Ghorbani‐Bidkorbeh · 2025 · Journal of Drug Delivery Science and Technology
24. The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents
    Núria Nadal‐Gratacós, Pol Puigseslloses, Laura Guzmán, Nicola Weiss, Eline Pottie, Clara Riera-Colomer, Virginie Lardeux, Nathalie Thiriet, Fu-Hua Wang, Liselott Källsten et al. · 2025 · Molecular Psychiatry
25. The effects of Kai-Xin-San in alleviating chronic social defeat stress-induced depression-like behaviors are associated with CD4+ T cells
    Yanbo Wang, Lijun Liu, Rui Jing, Yuanyuan Sun, Lei Yao, Xiaochun Zhang, Xiao Wu, Lihua Mu, Ping LIU, Yuan Hu · 2026 · Journal of Ethnopharmacology
26. Lifestyle physical activity coaching in outpatients with major depressive disorder (PACOUTPAT): study protocol for a randomized controlled trial on physical activity, depression, and quality of life
    Céline Stark, Johannes Beck, Anja Oswald, Anja Rogausch, Ann-Katrin Schreiner, Robyn Cody, Vivien Hohberg, Florian Knappe, Jan-Niklas Kreppke, Sebastian Ludyga et al. · 2026 · Trials
27. Advances in antidepressant pharmacotherapy: phase 3 evidence and clinical perspectives
    Alessandro Cuomo, Mario Pinzi, Andrea M. Fagiolini · 2026 · Expert Opinion on Pharmacotherapy
28. Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study
    George I. Papakostas, Prakash S. Masand, Anita Clayton, Vladimir Maletic, Julie Adams, Ludmyla Rekeda, Manpreet K. Singh, Majid Kerolous · 2026 · Neuropsychiatric Disease and Treatment
29. Acute Perturbations of Whole-Brain and Triple-Network Connectivity During Low- Frequency-Right TMS for Treatment Resistant Depression
    Elizabeth Gregory, Ahmad Samara, Ruiyang Ge, Hallee Shearer, Afifa Humaira, Tamara Vanderwal, Fidel Vila‐Rodriguez · 2026 · Neuromodulation Technology at the Neural Interface
30. Transforming depression research: The role of artificial intelligence and computational modelling
    Simran Suresh Somkuwar, Ujban Hussain, Dimak C. Sahu, Dr. Mohammad Tauqeer Sheikh, Sameer M. Sheikh, Manoj M. Gautam, Satish S. Meshram, Veena Shailendra Belgamwar · 2026 · In Silico Research in Biomedicine
31. Selective Anti‐Inflammatory Actions of Curcumin on Cytokine Pathways in Major Depressive Disorder
    Tangcong Chen, Yueyang Luo, Mengqi Niu, Jing Li, Mengdie Li, Yingqian Zhang, Michael H. J. Maes · 2026 · Brain and Behavior
32. Depression management and pharmacoepigenetics
    Sophia A. Walker, Arthur Su, Jayesh Kamath · 2022 · Elsevier eBooks
33. “Drugs of Abuse” as a “New Antidepressant”: - A Review on Pharmacological Mechanisms, Antidepressant Effects, and Abuse Potential
    Yoosuk An, Seon-Young Park, Ung Gu Kang · 2022 · 신경정신의학
34. An analysis of the fulfilment criteria for a medical experiment with regards to the use of intravenous ketamine in the treatment of drugresistant depression
    Maria Gutowska-Ibbs, Agnieszka Permoda-Pachuta, Hanna Karakuła‐Juchnowicz · 2023 · Current Problems of Psychiatry
35. Predictors of Treatment Response in Patients with Treatment-Resistant Depression: Outcomes of a Randomized Trial
    Karniza Khalid, Wei Chern Ang, Aimi Izwani Mohd Nazli, Ruzita Jamaluddin, Syed A. A. Rizvi · 2023 · Psychiatry International
36. Emotional Anatomy
    Haowei Han, Anita Gade, Francesca Ceci, Austin Dunn, Mark S. Nestor · 2023 · Cambridge University Press eBooks
37. Repetitive Transcranial Magnetic Stimulation With and Without Text4Support for the Treatment of Resistant Depression: Protocol for a Patient-Centered Multicenter Randomized Controlled Pilot Trial
    Medard Kofi Adu, Raquel da Luz Dias, Belinda Agyapong, Ejemai Eboreime, Adegboyega Oyekunbi Sapara, Mobolaji A. Lawal, Corina Chew, Karen Diamond Frost, Daniel Li, Michael Flynn et al. · 2023 · JMIR Research Protocols
38. Personalized Approach in the Management of Difficult-to-Treat and Treatment-Resistant Depression With Second-Generation Antipsychotics: A Delphi Statement
    Hansal Bhachech, Kamal Nath, Roop Sidana, Nilesh Shah, Rajesh Nagpal, Ramanathan Sathianathan, Ashutosh Kakkad, Krishnaprasad Korukonda · 2024 · Cureus
39. Treatment resistant depression: a critical reflection on missing oral narratives in dance therapy literature
    Neha Christopher · 2024 · Body Movement and Dance in Psychotherapy
40. Artificial Intelligence (AI) and Its Role in Depression
    Ashleigh A. Farmer, Bennett Lange, Shannon Kim, Suhrud Pathak, Sibi Chakravarthy, Jack DeRuiter, K. Reeta Vijayarani, Akila Ramanathan, Hanan Fahad Alharbi, Muralikrishnan Dhanasekaran · 2024 · Nutritional neurosciences
41. Impacts of Electroconvulsive Therapy on the Neurometabolic Activity in a Mice Model of Depression: An Ex Vivo 1H-[13C]-NMR Spectroscopy Study
    Ajay Sarawagi, Pratishtha Wadnerkar, Vrundika Keluskar, Narra Sai Ram, Jerald Mahesh Kumar, Anant Bahadur Patel · 2024 · Neuroglia
42. Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada
    K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden Gregory O’Neill · 2024 · PLoS ONE
43. Therapeutic Approaches to Tackle the Challenge of Depression That Is Resistant to Treatment–A Narrative Review
    Md. Rajdoula Rafe, Abdul Waris, Pranoy Saha · 2025 · Health Science Reports
44. Adaptation and Validation of a Treatment Expectations Scale for Hospitalized Patients-Spanish Patient Version
    Karol Gonzales-Valdivia, Katherine Ñaupa-Tito, Wilter C. Morales-García · 2025 · Healthcare
45. The impact of sex, variable stimulation mode and parameters on mfb-DBS evoked dopamine release dynamics in a rodent depression model
    Lidia Miguel Telega, Volker Arnd Coenen, Máté Daniel Döbrössy · 2025 · Journal of Affective Disorders
46. Psychopharmacotherapy of Depressive Disorders
    Erhan Kavakbasi, Bernhard Theodor Baune · 2022 · Springer eBooks
47. Genetic Signal Augmentation of Childhood-Onset and Treatment-Resistant Major Depression Reveals Distinct Biological Disorders
    Jeremy M Lawrence, Sophie Breunig, Lukas S. Schaffer, Alexander Sheppard, Katerina Zorina-Lichtenwalter, Andrew David Grotzinger · 2026 · medRxiv
48. Rezidivprophylaxe der Depression: Pharmakologie
    Pichit Buspavanich, Cornelia König, Mazda Adli · 2020 · PSYCH up2date
49. Treatment options for pharmacoresistant depression in routine clinical practice
    Eva Češková, Petr Šilhán · 2020 · Psychiatrie pro praxi
50. ESKETAMINAS IR GYDYMUI ATSPARI DEPRESIJA
    Vidmantas Grigas · 2021 · Health Sciences
51. Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy
    Dominic Pilon, Swapna U. Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté‐Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefèbvre, Kruti Joshi, Leslie Citrome · 2021 · Journal of Medical Economics
52. El mundo en bandeja
    Jordi Doce · 2012 · Cuadernos hispanoamericanos
53. Persistently Positive Urine Amphetamines Confirmation Testing
    Evan R. J. Goyette, Mark A Cervinski, Jacqueline A. Hubbard · 2021 · Clinical Chemistry
54. Psychopharmacotherapy of Depressive Disorders
    Erhan Kavakbasi, Bernhard Theodor Baune · 2021 · Springer eBooks
55. Translational Research Approach to Neurobiology and Treatment of Major Depression: From Animal Models to Clinical Treatment
    Michel Bourin · 2022 · Neuromethods
56. Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study
    J. Brouwer, Arne Risselada, Marinka de Wit, Janniek Lubberts, Henrieke Westerhuis, Bennard Doornbos, Hans Mulder · 2022 · International Journal of Clinical Pharmacy
57. Treatment Resistance and Advanced Therapies
    David S. Kroll · 2022 · Springer eBooks
58. La investigación sobre el tratamiento de depresión con base en registros de historia clínica: análisis de una experiencia en un hospital universitario
    María Isabel Molina–Echeverry, Roger Figueroa-Paz, María Mercedes Cardozo-Rengifo, Valentina Galindo‐Velasco, Hernán G. Rincón-Hoyos · 2022 · Revista Colombiana de Psiquiatría
59. Deep brain stimulation for the treatment of major depressive disorder: complex psychiatric aspects
    Przemyslaw Maciej Waszak · 2022 · Postępy Psychiatrii i Neurologii
60. Genetics of nonpharmacological treatments of depression
    Raffaella Zanardi, Matteo Carminati, Francesco Attanasio, Chiara Fabbri, Alessandro Serretti · 2022 · Psychiatric Genetics
61. Depressed Patients who do Not Believe they Deserve to Get Better: Prevalence, Clinical Characteristics, and Treatment Outcomes
    Mark A. Zimmerman, Lena Becker · 2023 · Annals of Clinical Psychiatry
62. Treating Depression in Clinical Practice: New Insights on the Multidisciplinary Use of Tradozone
    Umberto Albert, Carmine Tomasetti, Camillo Marra, Francesca Neviani, Alessandro Pirani, Daiana Taddeo, Orazio Oz. Zanetti, Giuseppe Maina · 2023 · Preprints.org
63. Linking major depressive disorder pathogenesis with kynurenine pathway - a literature review
    Dominik SZAWICA, Aleksandra Kuźniar, Kamila Fularska, Michał Oleszko, Edward WĄSIEWICZ · 2023 · Journal of Education Health and Sport
64. Diretrizes clínicas para tratamento da depressão: análise de fatores associados à qualidade e comparação de recomendações para pacientes não respondedores e com depressão resistente
    Franciele Cordeiro Gabriel · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
65. Neue Psychiatrie
    Felix Hasler · 2023 · transcript Verlag eBooks
66. Efficacy of Ketamine Therapy in the Treatment of Refractory Major Depressive Disorder
    Helena van Oers · 2023 · Journal of Exploratory Research in Pharmacology
67. Depresión resistente al tratamiento en Argentina: resultados de un análisis longitudinal del estudio TRAL
    Christian Lupo, Gerardo García Bonetto, Ricardo Marcelo Corral, Manuel Vilapriño, Hernán Alessandria, Gabriela Ana KANEVSKY, Sergio Perocco · 2023 · Vertex Revista Argentina de Psiquiatría
68. Economic Evaluation of Mental Health Interventions
    Huajie Jin, Ali Jalali, Ben F. M. Wijnen, Yuhua Bao · 2023 · Frontiers research topics
69. A Case Report: Young Adult with Drug Treatment-Resistant Depression-Induced Suicide Attempt Successfully Treated with Electroconvulsive Therapy
    Denada Florencia Leona · 2023 · INSOLOGI Jurnal Sains dan Teknologi
70. GYDYMUI ATSPARI DEPRESIJA: RIZIKOS VEIKSNIAI IR GYDYMAS
    Miglė Miglinaitė · 2024 · Health Sciences
71. Design of Experimental Approach for Method Development, Validation and Stability of Rp-Hplc for Simultaneous Estimation of Levosulpiride and Cannabidiol: Determining Pharmacokinetic Studies
    Iqra Zai, Suryadev Sharma, Saeem Ahmad, Meenakshi Dahiya, Robin Kumar, Mohd Aqil, Yasmin Sultana · 2024 · SSRN Electronic Journal
72. Dépression résistante aux traitements chez les personnes âgées
    Philippe Thomas, C. Hazif-Thomas · 2024 · NPG. Neurologie, psychiatrie, gériatrie/NPG
73. Magnetic Seizure Therapy in Management of Depression: A Narrative Review
    Pawan Sharma, Swarndeep Singh · 2024 · Current Behavioral Neuroscience Reports
74. Psychometric properties of the Arabic Fear of Happiness Scale-5 items (FHS-5) in a non-clinical sample of Arabic-speaking adults
    Marie Anne El Khoury, Diana N. Malaeb, Fouad Sakr, Mariam Dabbous, Feten Fekih‐Romdhane, Souheil R. Hallit, Sahar Obeïd · 2024 · Research Square
75. Comorbidity, Treatment, and Service Utilization Patterns in Difficult-to-Treat Depression Patients: A Retrospective Study in a Portuguese Community Mental Health Team
    João Gouveia, Marta R. Neves, Nuno Gonçalo Gomes Fernandes Madeira, Vítor Santos, António Macedo · 2024 · Medicina
76. Volitional Regulation and Transferable Patterns of Midbrain Oscillations
    Hung‐Yun Lu, Yi Zhao, Hannah M. Stealey, Cole R. Barnett, Philippe N. Tobler, Samantha R. Santacruz · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
77. 2013-2024 YILLARI ARASINDA FDA ONAYI ALMIŞ ANTİDEPRESANLAR VE YENİ ANTİDEPRESAN İLAÇ GELİŞTİRME ÇALIŞMALARI
    Mert Karacık, Begüm Evranos Aksöz · 2024 · Ankara Universitesi Eczacilik Fakultesi Dergisi
78. A Comprehensive Approach to Treatment-Resistant Depression: Addressing Gender Disparities, Psychotherapy Integration, and Emerging Avenues
    Aysesu Bozdogan · 2024 · PsyPag Quarterly
79. Volitional Regulation and Transferable Patterns of Midbrain Oscillations
    Hung‐Yun Lu, Yi Zhao, Hannah M. Stealey, Cole R. Barnett, Philippe N. Tobler, Samantha R. Santacruz · 2025 · Journal of Neuroscience
80. Characteristics of patients with major depressive disorder eligible for and prescribed esketamine, treatment outcomes and physician experiences: a physician and patient survey in the United States
    Manish K. Jha, Amanda Teeple, Jason Shepherd, Alexander Gillespie, Nikisha Grant, Ashley Mortimer, Sophie Kirkman, Chloe Middleton‐Dalby, Kruti Joshi · 2025 · Current Medical Research and Opinion
81. Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment
    Qian He, Adam N. Bennett, Kei Hang Katie Chan · 2025 · Springer eBooks
82. Increased Use and State-Level Variation of Esketamine Prescriptions Among Medicare Patients
    Luke R. Cavanah · 2025 · American Journal of Psychiatry Residents Journal
83. Supervised Machine-Learning Classification of Treatment-Resistant Depression in U.S. Claims Data
    Vicki K. Wing, Jason Lerner, Patrick Clarke, Shane J. O’Connor, Sydney Tran, Jonathan D. Darer, Jaspreet Singh Gill, Lucinda Strycker Orsini · 2025 · medRxiv
84. A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome
    Monica Fahmy, Youssef Bessada, Cassandra Ramsey, J.R. Zigun · 2025 · Mental Health Clinician
85. Differential Impact of Extracts from Distinct Sceletium Tortuosum Ecotypes on Central Neurotransmitter Concentrations in C57bl/6 Mice
    Catherine H. Kaschula, Anna‐Mart Engelbrecht, Nokwanda Pearl Makunga, Magriet Muller, André J. de Villiers, Kamano Angela Mochoele, Sarel Jacobus Brand, Jo-Anne Stroebel, Willem A. L. van Otterlo, De Wet Wolmarans · 2025 · SSRN Electronic Journal
86. Prolactin-Releasing Peptide System as a Potential Mechanism of Stress Coping: Studies in Male Rats
    Evelin Szabó, V. Kormos, Zsuzsanna E Tóth, D. Zelena, Anita Kovács · 2025 · International Journal of Molecular Sciences
87. Repeated Electroconvulsive Shock Transiently Affects Cognition and Neurometabolism in Mice
    Ajay Sarawagi, Sanjana Sinha, Anant Bahadur Patel · 2025 · Journal of Ect
88. Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression
    Kristin Clemens, Amanda Teeple, Benoît Rive, Noam Y. Kirson, Urvi S. Desai, Jason Doran, Diab Eid, Alice Qu, Hannah E. Bowrey, Kruti Joshi · 2025 · Journal of Comparative Effectiveness Research
89. Transcriptional profiling of antidepressant ketamine and electroconvulsive therapy treatment
    Artemis Zavaliangos‐Petropulu, Ginny Ghang, Toni A. Boltz, Paloma Pfeiffer, Lingyu Zhan, Brandon Taraku, Eliza L. Congdon, Randall T. Espinoza, Katherine L. Narr, Roel A. Ophoff · 2026 · Translational Psychiatry
90. Comparative effectiveness of moderate treadmill training and venlafaxine treatment on long-lasting brain changes induced by prenatal dexamethasone exposure
    Katarzyna Głombik, Magdalena Kukla‐Bartoszek, Maciej Suski, Katarzyna Curzytek, Beata Grygier, Agnieszka Basta‐Kaim · 2025 · Neuropharmacology
91. Efficacy and safety of esketamine in treatment of drug-resistant depression: A review of clinical and survey studies and future therapeutic perspectives
    Daniel Szawarnoga, Wojciech Sołtys · 2025 · Polish Annals of Medicine
92. Eletroconvulsoterapia no manejo dos transtornos do humor: evidências, indicações clínicas e avanços terapêuticos
    Luís Fernando Boaventura Gonçalves, Monica Montemor Bertazo, Diêgo Ferraz Oliveira, Cristiane del Corsso, Marcelo Henrique Vaz de Lima, Leonardo Gomes Moreira, Bruno Oliveira de Castro, Gabriel Machura Meurer · 2025 · Caderno Pedagógico
93. Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment
    Qian He, Adam N. Bennett, Kei Hang Katie Chan · 2025 · Springer eBooks
94. Neurensin-2 is a negative regulator of CB1 receptor
    Yumna Abu Ghanem, Liora Dorfman-Yahad, Hadas Catane Hovav, Laila Agbariya, Adi Cohen, Hila Yehuda, Gali Umschweif · 2025 · Biochemical Pharmacology
95. Sildenafil, alleen en in kombinasie met imipramien, vertoon antidepressantagtige effekte in ’n tydafhanklikesensitiseringgeïnduseerde (TAS-) rotmodel van behandelingsweerstandige depressie
    Juandré Lambertus Bernardus Saayman, Brian Herbert Harvey, G Wegener, Christiaan Beyers Brink · 2024 · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie
96. Sildenafil, alone and in combination with imipramine, displays antidepressant-like effects in a time-dependent sensitisation-induced (TDS) rat model of treatment-resistant depression
    Juandré Lambertus Bernardus Saayman, Brian Herbert Harvey, G Wegener, Christiaan Beyers Brink · 2024 · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie
97. REWARD – rTMS Effects in Adolescent Depression and Behavioral Addictions
    Johanna K. Loy, Alexander Krieg, Lena Pokorny, Stephan Bender · 2025 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
98. O uso de cloridrato de escetamina intranasal em paciente com depressão resistente ao tratamento e risco de suicidio: relato de caso
    Coraima Beatriz Anaya Linan, Antônio Furlanetto Corte, João Renato Garcia e Silva, Gabriela Pinho Fillmann, Alessandro Batista Soares, Sayra Catalina Coral Castro, Marco Antônio Pacheco, Lucas Spanemberg · 2025 · Jornal Brasileiro de Psiquiatria
99. No differences in treatment response between atypical depression and major depressive disorder after repetitive transcranial magnetic stimulation in a clinical sample
    Johan Bengtsson, Hannes Svensson, Ida Blomqvist · 2025 · Nordic Journal of Psychiatry
100. Additional file 1 of The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
     Claudia Savia Guerrera, Giuseppe Alessio Platania, Francesco Maria Boccaccio, Pierfrancesco Sarti, Simone Varrasi, Chiara Colliva, Grasso, Margherita, Simona De Vivo, Davide Cavallaro, Tascedda, Fabio et al. · 2023 · Figshare